Private Advisory Group’s AbbVie ABBV Stock Holding History

Private Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$513K	Buy	2,359 +411	+21%	+$91.2K	0.03%	198
2025 Q4	$445K	Sell	1,948 -109	-5%	-$24.8K	0.03%	165
2025 Q3	$476K	Buy	2,057 +494	+32%	+$101K	0.04%	156
2025 Q2	$290K	Sell	1,563 -315	-17%	-$58.5K	0.03%	180
2025 Q1	$393K	Sell	1,878 -70	-4%	-$13.6K	0.04%	151
2024 Q4	$346K	Buy	1,948 +610	+46%	+$112K	0.04%	163
2024 Q3	$264K	Sell	1,338 -54	-4%	-$10.1K	0.03%	175
2024 Q2	$239K	Sell	1,392 -312	-18%	-$51.7K	0.03%	161
2024 Q1	$310K	Buy	+1,704	New	+$294K	0.04%	156
2023 Q1	–	Sell	-1,260	Closed	-$204K	–	198
2022 Q4	$204K	Buy	+1,260	New	+$193K	0.04%	185
2022 Q3	–	Sell	-1,721	Closed	-$264K	–	179
2022 Q2	$264K	Buy	+1,721	New	+$263K	0.06%	138
2018 Q1	–	Sell	-3,825	Closed	-$370K	–	101
2017 Q4	$370K	Buy	+3,825	New	+$360K	0.2%	98

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Private Advisory Group's ABBV Position: Q1 2026 in Review

Private Advisory Group increased its AbbVie (ABBV) stake by 21% in Q1 2026, buying an estimated $91.2K and bringing the position to 2,359 shares worth $513K. The position accounts for 0.03% of the portfolio, ranked #198.

Private Advisory Group first reported a position in ABBV in Q4 2017 and has held it in 12 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Private Advisory Group held 2,359 shares of AbbVie worth $513K as of Q1 2026.
Private Advisory Group bought 411 AbbVie shares in Q1 2026, an estimated $91.2K.
AbbVie made up 0.03% of Private Advisory Group's portfolio in Q1 2026, its #198 holding.
Private Advisory Group first reported a position in AbbVie in Q4 2017 and has held it in 12 quarters since.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Private Advisory Group's 13F filing for Q1 2026, filed 8 May 2026.